Skip to main content

Table 2 Antimicrobial resistance rates (%) of Escherichia coli isolates of patients with female genital tract infection

From: Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections

Antimicrobial agent

Total (n = 91)

ESBL (n = 18)

Non-ESBL (n = 73)

ST131a (n = 20)

O25b-ST131 (n = 14)

Non-ST131 (n = 71)

Ampicillin

67 (61/91)

100 (18/18)

59 (43/73)

85 (17/20)

79 (11/14)

62 (44/71)

Ampicillin/sulbactam

27 (25/91)

33 (6/18)

26 (19/73)

20 (4/20)

21 (3/14)

30 (21/71)

Piperacillin

65 (59/91)

100 (18/18)

56 (41/73)

85 (17/20)

79 (11/14)

59 (42/71)

Piperacillin/Tazobactam

0 (0/91)

0 (0/18)

0 (0/73)

0 (0/20)

0 (0/14)

0 (0/71)

Cefuroxime

25 (23/91)

94 (17/18)

8 (6/73)

40 (8/20)

36 (5/14)

21 (15/71)

Cefotaxime

25 (23/91)

94 (17/18)

7 (5/73)

40 (8/20)

36 (5/14)

20 (14/71)

Ceftazidime

24 (22/91)

94 (17/18)

7 (5/73)

40 (8/20)

36(5/14)

20 (14/71)

Cefoxitin

7 (6/91)

6 (1/18)

7 (5/73)

5 (1/20)

7 (1/14)

7 (5/71)

Cefepime

22 (20/91)

100 (18/18)

3 (2/73)

35 (7/20)

29 (4/14)

18 (13/71)

Aztreonam

22 (20/91)

94 (17/18)

4 (3/73)

35 (7/20)

29 (4/14)

18 (13/71)

Meropenem

0 (0/91)

0 (0/18)

0 (0/73)

0 (0/20)

0 (0/14)

0 (0/71)

Doripenem

0 (0/91)

0 (0/18)

0 (0/73)

0 (0/20)

0 (0/14)

0 (0/71)

Imipenem

0 (0/91)

0 (0/18)

0 (0/73)

0 (0/20)

0 (0/14)

0 (0/71)

Ciprofloxacin

36 (33/91)

67 (12/18)

29 (21/73)

40 (8/20)

50 (7/14)

35 (25/71)

Levofloxacin

30 (27/91)

61 (11/18)

22 (16/73)

40 (8/20)

50 (7/14)

27 (19/71)

Gentamicin

25 (23/91)

33 (6/18)

23 (17/73)

25 (5/20)

21 (3/14)

25 (18/71)

Tobramycin

18 (16/91)

22 (4/18)

16 (12/73)

15 (3/20)

14 (2/14)

18 (13/71)

Amikacin

1 (1/91)

0 (0/18)

1 (1/73)

0 (0/20)

0 (0/14)

1 (1/71)

Cotrimoxazole

40 (36/91)

44 (8/18)

38 (28/73)

45 (9/20)

43 (6/14)

38 (27/71)

Tigecycline

0 (0/91)

0 (0/18)

0 (0/73)

0 (0/20)

0 (0/14)

0 (0/71)

Colistin

0 (0/91)

0 (0/18)

0 (0/73)

0 (0/20)

0 (0/14)

0 (0/71)

  1. aST131 Sequence type131 (both O25 and O16), O25b Serogroup O25b, O16 Serogroup O16, ESBL, ESBL-producer; non-ESBL; non-ESBL producer